RUBICON Share Price | Rubicon Research Ltd Stock Analysis & Recommendation

Q: When is the next results date for Rubicon Research Ltd?

The next results date for Rubicon Research Ltd is scheduled for 03 February 2026.

Q: Why is Rubicon Research Ltd falling/rising?

As of 08-May, Rubicon Research Ltd's stock price is rising, currently at 954.70, with a change of 2.8 (0.29%) upward. This increase can be attributed to several factors. Firstly, the stock has shown strong performance over the past month, with a gain of 19.56%, significantly outperforming the Sensex, which has declined by 0.30% during the same period. Year-to-date, the stock has also demonstrated impressive growth of 40.85%, while the Sensex has fallen by 9.26%. Additionally, today's performance indicates that Rubicon Research Ltd has outperformed its sector by 0.33%. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, which is generally a positive indicator of momentum. Furthermore, there has been a notable increase in investor participation, with delivery volume rising by 132.03% compared to the 5-day average, suggesting heightened interest and confidence among investors. Overall, these factors contribute to the upward movement in the stock price of Rubicon Research Ltd.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.34 lacs (-1.62%) Volume

Shareholding (Mar 2026)

FII

7.54%

Held by 28 FIIs

DII

2.57%

Held by 11 DIIs

Promoter

59.86%

When is the next results date for Rubicon Research Ltd?

28-Jan-2026

The next results date for Rubicon Research Ltd is 03 February 2026.

View full answer

Why is Rubicon Research Ltd falling/rising?

09-May-2026

As of 08-May, Rubicon Research Ltd's stock price is rising to 954.70, reflecting a 0.29% increase. This growth is driven by strong monthly and year-to-date performance, outpacing the Sensex, along with positive momentum indicators and increased investor interest.

View full answer

Which are the latest news on Rubicon Research?

09-May-2026

No latest news for Rubicon Research found.

Compare Rubicon Research with Similar Stocks

Granules India Alembic Pharma Cohance Life

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 15,704 Cr (Small Cap)

P/E

75.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.60

Return on Equity

22.13%

Price to Book

20.70

Revenue and Profits:

Net Sales:

476 Cr

(Quarterly Results - Dec 2025)

Net Profit:

73 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

21.81%

6 Months

52.39%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Rubicon Research for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.94

Debt to EBITDA (avg)

1.56

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.27

Tax Ratio

24.96%

Dividend Payout Ratio

0.23%

Pledged Shares

Institutional Holding

17.55%

ROCE (avg)

22.12%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

20.64

EV to EBIT

67.57

EV to EBITDA

59.56

EV to Capital Employed

13.30

EV to Sales

14.97

PEG Ratio

Dividend Yield

ROCE (Latest)

19.68%

ROE (Latest)

22.13%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bearish

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 12 Schemes (7.14%)

FIIs

Held by 28 FIIs (7.54%)

Promoter with highest holding

General Atlantic Singapore Rr Pte Ltd (35.89%)

Highest Public shareholder

Shivanand Shankar Mankekar Huf (13.54%)

Individual Investors Holdings

2.82%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -10.33% vs 21.02% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -18.84% vs 30.33% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "301.71",
          "val2": "336.47",
          "chgp": "-10.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.24",
          "val2": "79.11",
          "chgp": "-21.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.51",
          "val2": "9.21",
          "chgp": "-18.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "37.18",
          "val2": "45.81",
          "chgp": "-18.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.63%",
          "val2": "23.51%",
          "chgp": "-2.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "614.49",
          "val2": "528.16",
          "chgp": "16.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "142.24",
          "val2": "144.68",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "18.06",
          "val2": "16.26",
          "chgp": "11.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "80.96",
          "val2": "89.04",
          "chgp": "-9.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.15%",
          "val2": "27.39%",
          "chgp": "-4.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "916.20",
          "val2": "773.03",
          "chgp": "18.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.48",
          "val2": "208.58",
          "chgp": "-1.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "25.57",
          "val2": "23.51",
          "chgp": "8.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "118.14",
          "val2": "127.27",
          "chgp": "-7.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.32%",
          "val2": "26.98%",
          "chgp": "-4.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,073.84",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "269.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "34.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "167.54",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.13%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

301.71

336.47

-10.33%

Operating Profit (PBDIT) excl Other Income

62.24

79.11

-21.32%

Interest

7.51

9.21

-18.46%

Exceptional Items

0.00

Standalone Net Profit

37.18

45.81

-18.84%

Operating Profit Margin (Excl OI)

20.63%

23.51%

-2.88%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -10.33% vs 21.02% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -18.84% vs 30.33% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

614.49

528.16

16.35%

Operating Profit (PBDIT) excl Other Income

142.24

144.68

-1.69%

Interest

18.06

16.26

11.07%

Exceptional Items

0.00

Standalone Net Profit

80.96

89.04

-9.07%

Operating Profit Margin (Excl OI)

23.15%

27.39%

-4.24%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

916.20

773.03

18.52%

Operating Profit (PBDIT) excl Other Income

204.48

208.58

-1.97%

Interest

25.57

23.51

8.76%

Exceptional Items

0.00

Standalone Net Profit

118.14

127.27

-7.17%

Operating Profit Margin (Excl OI)

22.32%

26.98%

-4.66%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

1,073.84

Operating Profit (PBDIT) excl Other Income

269.89

Interest

34.29

Exceptional Items

0.00

Standalone Net Profit

167.54

Operating Profit Margin (Excl OI)

25.13%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Rubicon Research Ltd

Rubicon Research Ltd

Small Cap

Pharmaceuticals & Biotechnology

Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as `Rubicon Consultants Private Limited', with the RoC. Subsequently, the Company's name was changed from `Rubicon Consultants Private Limited' to `Rubicon Research Private Limited' to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002.

Company Coordinates

No Company Details Available